| Ytd | 18.18% | |
| 1y | -1.89% |
| Open | 22.99 | Prev Close | 22.80 | Low | 22.59 | High | 23.04 | Mkt Cap | 11.68B |
| Vol | 1.23M | Avg Vol | 6.37M | EPS | -1.88 | P/E | N/A | Forward P/E | 11.19 |
| Beta | 0.60 | Short Ratio | 3.66 | Inst. Own | 110.10% | Dividend | 0.04 | Div Yield | 0.17 |
| Ex Div Date | 08-28 | Earning | 10-29 | 50-d Avg | 25.01 | 200-d Avg | 20.59 | 1yr Est | 28.73 |
CVS, Steris and Baxter are oversold healthcare stocks with RSI readings near or below 30, potentiall
Bank of America Corp DE acquired a new position in Baxter International Inc. (NYSE: BAX) in the seco
NewEdge Advisors LLC boosted its position in shares of Baxter International Inc. (NYSE: BAX) by 22.6
Baxter International (NYSE: BAX - Get Free Report) and TELA Bio (NASDAQ: TELA - Get Free Report) are
Baxter International Inc. (BAX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
On Aug. 31, 2026, Richard Pzena (Trades, Portfolio)'s firm, Pzena Investment Management, significant
Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs
Barbara Oil Co. purchased a new position in Baxter International Inc. (NYSE: BAX) in the second quar
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, tod
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) t
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) t
On August 17, 2026, Baxter International Inc (BAX) shares fell 3.1% to a current price of $25.91. Th
On June 30, 2026, Richard Pzena (Trades, Portfolio)'s firm executed a significant addition to its ex
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) t
On August 03, 2026, Baxter International Inc (BAX) shares rose 7.4% today, bringing the current pric
Baxter International has shown early signs of a turnaround, with improving execution and raised reve
It scored double beats on analyst estimates. It also lifted its guidance on both the top and bottom
TD Cowen analyst Joshua Jennings maintains Baxter International (NYSE:BAX) with a Hold and raises
Wells Fargo analyst Larry Biegelsen maintains Baxter International (NYSE:BAX) with a Equal-Weight
Stifel analyst Rick Wise maintains Baxter International (NYSE:BAX) with a Hold and raises the pri
Citigroup analyst Joanne Wuensch upgrades Baxter International (NYSE:BAX) from Sell to Neutral an
On July 30, 2026, Baxter International Inc (BAX) shares rose 8.0%, closing at $26.75. This increase
Baxter beats second-quarter earnings and revenue estimates, posts broad-based segment growth and rai
Baxter International Inc. (BAX) Q2 2026 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX) stock is trading higher on Thursday after the company reported
Baxter stock climbs after second-quarter earnings and revenue topped estimates as the company raised
Baxter International (NYSE:BAX) raises FY2026 Adj EPS guidance from $1.85-$2.05 to $1.95-$2.15 vs $1
Baxter Intl (NYSE:BAX) reported quarterly earnings of $0.54 per share which beat the analyst consens
UBS analyst Patrick Wood maintains Baxter International (NYSE:BAX) with a Neutral and raises the
Stifel analyst Rick Wise maintains Baxter International (NYSE:BAX) with a Hold and raises the pri
TD Cowen analyst Joshua Jennings maintains Baxter International (NYSE:BAX) with a Hold and raises
Goldman Sachs analyst David Roman maintains Baxter International (NYSE:BAX) with a Neutral and ra
Evercore ISI Group analyst Vijay Kumar maintains Baxter International (NYSE:BAX) with a Outperfor
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-positive-pre
Citigroup analyst Joanne Wuensch downgrades Baxter International (NYSE:BAX) from Neutral to Sell
Barclays analyst Matt Miksic maintains Baxter International (NYSE:BAX) with a Overweight and rais
Baxter tops earnings, but profit plunges 35% as tariffs and manufacturing costs rise; outlook for 20
Baxter International (NYSE:BAX) affirms FY2026 Adj EPS guidance from $1.85-$2.05 to $1.85-$2.05 vs $
Baxter International (NYSE:BAX) affirms FY2026 Adj EPS guidance from $1.85-$2.05 to $1.85-$2.05 vs $
Baxter Intl (NYSE:BAX) reported quarterly earnings of $0.37 per share which beat the analyst consens
Evercore ISI Group analyst Vijay Kumar maintains Baxter International (NYSE:BAX) with a Outperfor
Oil prices have risen. Here's how Strait of Hormuz tensions could soon increase healthcare costs
Baxter warns of an EU-wide ifosfamide shortage until next year after manufacturing disruption, with
https://www.ema.europa.eu/en/documents/other/medicine-shortage-communication-msc-holoxan-tronoxal-mi
Baxter Intl (NYSE:BAX) is looking for FY2026 Adj EPS of $1.85-$2.05 vs $2.25 analyst estimate. sees
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the departure of exec
A volatile Thursday rattled Wall Street, with technology and software stocks sliding across the boar